ArticleOpen forum infectious diseases2026

Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics.

Katerina A Christopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.